The GCC in-vitro diagnostic devices market was worth US$ 1091 Million in 2017. The market is further projected to reach a value of US$ 1830 Million by 2023, at a CAGR of around 9% during 2018-2023. In-vitro diagnostics (IVD) refer to clinical tests which are conducted on different bodily samples such as urine, tissue, blood, etc. for detecting infections and diseases. There are various devices which can be used individually or in combinations with each other for in-vitro diagnosis including calibrators, specimen receptacles, reagents and control materials. In the GCC countries, there has been a rise in the demand for IVD devices on account of ageing population, rising prevalence of lifestyle diseases and a growth in the healthcare sector of the region. Apart from this, the market is also being impacted by the establishment of standalone centers, independent diagnostics chains and academic institutes.
GCC In-Vitro Diagnostic Devices Market Driver
Breakup by End-user:
The in-vitro diagnostic devices market has been segmented on the basis of various end-users including hospital-based centers, diagnostics chains, standalone centers, patient self-testing and academic institutes. Amongst these, in-vitro diagnostic devices are majorly used in hospital-based centers.
Breakup by Application:
The market has also been segmented on the basis of application. Some of the major applications covered in the report include Infectious diseases, diabetes, blood test, nephrology, cardiology, oncology and autoimmune diseases.
On a geographical front, Saudi Arabia enjoys the leading position in the GCC in-vitro diagnostic devices market. Other major regions include United Arab Emirates, Kuwait, Qatar, Oman and Bahrain.
This report provides a deep insight into the GCC in-vitro diagnostic devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the in-vitro diagnostic devices market in any manner.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at